Please use this identifier to cite or link to this item: https://scidar.kg.ac.rs/handle/123456789/8347
Full metadata record
DC FieldValueLanguage
dc.rights.licenseBY-NC-ND-
dc.contributor.authorVolarevic, Vladislav-
dc.contributor.authorDjokovic B.-
dc.contributor.authorJankovic M.-
dc.contributor.authorHarrell C.-
dc.contributor.authorFellabaum, Crissy-
dc.contributor.authorDjonov V.-
dc.contributor.authorArsenijevic, Nebojsa-
dc.date.accessioned2020-09-19T15:29:15Z-
dc.date.available2020-09-19T15:29:15Z-
dc.date.issued2019-
dc.identifier.issn1021-7770-
dc.identifier.urihttps://scidar.kg.ac.rs/handle/123456789/8347-
dc.description.abstract© 2019 The Author(s). Background: Cisplatin (cis-diamminedichloroplatinum II, CDDP) is one of the most effective chemotherapeutic agents. However, its clinical use is limited due to the severe side effects, including nephrotoxicity and acute kidney injury (AKI) which develop due to renal accumulation and biotransformation of CDDP. The alleviation or prevention of CDDP-caused nephrotoxicity is currently accomplished by hydration, magnesium supplementation or mannitol-induced forced diuresis which is considered for high-dose CDDP-treated patients. However, mannitol treatment causes over-diuresis and consequent dehydration in CDDP-treated patients, indicating an urgent need for the clinical use of safe and efficacious renoprotective drug as an additive therapy for high dose CDDP-treated patients. Main body: In this review article we describe in detail signaling pathways involved in CDDP-induced apoptosis of renal tubular cells, oxidative stress and inflammatory response in injured kidneys in order to pave the way for the design of new therapeutic approaches that can minimize CDDP-induced nephrotoxicity. Most of these molecular pathways are, at the same time, crucially involved in cytotoxic activity of CDDP against tumor cells and potential alterations in their function might mitigate CDDP-induced anti-tumor effects. Conclusion: Despite the fact that many molecules were designated as potential therapeutic targets for renoprotection against CDDP, modulation of CDDP-induced nephrotoxicity still represents a balance on the knife edge between renoprotection and tumor toxicity.-
dc.rightsopenAccess-
dc.rights.urihttps://creativecommons.org/licenses/by-nc-nd/4.0/-
dc.sourceJournal of Biomedical Science-
dc.titleMolecular mechanisms of cisplatin-induced nephrotoxicity: A balance on the knife edge between renoprotection and tumor toxicity-
dc.typereview-
dc.identifier.doi10.1186/s12929-019-0518-9-
dc.identifier.scopus2-s2.0-85062865619-
Appears in Collections:Faculty of Medical Sciences, Kragujevac

Page views(s)

150

Downloads(s)

12

Files in This Item:
File Description SizeFormat 
10.1186-s12929-019-0518-9.pdf2.58 MBAdobe PDFThumbnail
View/Open


This item is licensed under a Creative Commons License Creative Commons